These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17533012)

  • 1. Hypoxia-inducible transcription factors and their role in renal disease.
    Eckardt KU; Bernhardt W; Willam C; Wiesener M
    Semin Nephrol; 2007 May; 27(3):363-72. PubMed ID: 17533012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible factor-1 (HIF-1).
    Ke Q; Costa M
    Mol Pharmacol; 2006 Nov; 70(5):1469-80. PubMed ID: 16887934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human HIF (hypoxia-inducible factor)-3alpha gene is a HIF-1 target gene and may modulate hypoxic gene induction.
    Tanaka T; Wiesener M; Bernhardt W; Eckardt KU; Warnecke C
    Biochem J; 2009 Oct; 424(1):143-51. PubMed ID: 19694616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anemia and cerebral outcomes: many questions, fewer answers.
    Hare GM; Tsui AK; McLaren AT; Ragoonanan TE; Yu J; Mazer CD
    Anesth Analg; 2008 Oct; 107(4):1356-70. PubMed ID: 18806052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer.
    Lee BL; Kim WH; Jung J; Cho SJ; Park JW; Kim J; Chung HY; Chang MS; Nam SY
    Carcinogenesis; 2008 Jan; 29(1):44-51. PubMed ID: 17984117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain.
    Schneider C; Krischke G; Keller S; Walkinshaw G; Arend M; Rascher W; Gassmann M; Trollmann R
    Brain Res; 2009 Jul; 1280():43-51. PubMed ID: 19450570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADP-ribose) polymerase 1 promotes tumor cell survival by coactivating hypoxia-inducible factor-1-dependent gene expression.
    Elser M; Borsig L; Hassa PO; Erener S; Messner S; Valovka T; Keller S; Gassmann M; Hottiger MO
    Mol Cancer Res; 2008 Feb; 6(2):282-90. PubMed ID: 18314489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
    Hewitson KS; Schofield CJ; Ratcliffe PJ
    Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cross-talk between NF-kappaB and HIF-1: further evidence for a significant liaison.
    Görlach A; Bonello S
    Biochem J; 2008 Jun; 412(3):e17-9. PubMed ID: 18498249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of HIF: asparaginyl hydroxylation.
    Peet D; Linke S
    Novartis Found Symp; 2006; 272():37-49; discussion 49-53, 131-40. PubMed ID: 16686428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current understanding of HIF in renal disease.
    Rosenberger C; Rosen S; Heyman SN
    Kidney Blood Press Res; 2005; 28(5-6):325-40. PubMed ID: 16534228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
    Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
    Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
    Martínez-Sánchez G; Giuliani A
    J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible factor-1alpha under the control of nitric oxide.
    Brüne B; Zhou J
    Methods Enzymol; 2007; 435():463-78. PubMed ID: 17998069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intravenous anesthetics barbiturates inhibit hypoxia-inducible factor 1 activation.
    Wakamatsu T; Tanaka T; Oda S; Nishi K; Harada H; Daijo H; Takabuchi S; Kai S; Fukuda K; Hirota K
    Eur J Pharmacol; 2009 Sep; 617(1-3):17-22. PubMed ID: 19595685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1.
    Toffoli S; Roegiers A; Feron O; Van Steenbrugge M; Ninane N; Raes M; Michiels C
    Angiogenesis; 2009; 12(1):47-67. PubMed ID: 19184477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
    Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
    Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual effect of echinomycin on hypoxia-inducible factor-1 activity under normoxic and hypoxic conditions.
    Vlaminck B; Toffoli S; Ghislain B; Demazy C; Raes M; Michiels C
    FEBS J; 2007 Nov; 274(21):5533-42. PubMed ID: 17916190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypoxic inducible stress response as a target for cancer drug discovery.
    Welsh SJ; Koh MY; Powis G
    Semin Oncol; 2006 Aug; 33(4):486-97. PubMed ID: 16890803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxynitrite as an alternative donor of oxygen in HIF-1alpha proline hydroxylation under low oxygen availability.
    Sumbayev VV; Yasinska IM
    Free Radic Res; 2006 Jun; 40(6):631-5. PubMed ID: 16753841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.